Skip to Content

Notice

Memorandum of Understanding between the Food and Drug Administration, Forensic Chemistry Center and the Federal Bureau of Investigation

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between the Food and Drug Administration and the Federal Bureau of Investigation (FBI). The purpose of this MOU is to establish the general policies and procedures that will govern administrative, logistical, and operational support to FBI missions including cost reimbursable activities.

DATES:

The agreement became effective December 22, 2004.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

For the FDA: Fred Fricke, Food and Drug Administration, Forensic Chemistry Center, 6751 Steger Dr., Cincinnati, OH 45237, 513-679-2700.

For the FBI: David L. Wilson, Federal Bureau of Investigation Laboratory, Chemical Biological Sciences Unit, Quantico, VA 22135, 703-632-7766.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the Federal Register, the agency is publishing notice of this MOU.

Start Signature

Dated: September 20, 2005.

Jeffrey Shuren,

Assistant Commissioner for Policy.

End Signature Start Printed Page 56713

Start Printed Page 56714

Start Printed Page 56715

Start Printed Page 56716

Start Printed Page 56717

Start Printed Page 56718

Start Printed Page 56719

Start Printed Page 56720

End Supplemental Information

BILLING CODE 4160-01-S

[FR Doc. 05-19339 Filed 9-27-05; 8:45 am]

BILLING CODE 4160-01-C